Objectif
The health of the EC population has never been better. However, serious public health problems remain, which cannot be ignored including high levels of premature death due to cardiovascular diseases. Thus, new preventive, diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseases are needed. The atherosclerotic changes of the vascular wall are central in the development of cardiovascular complications. The traditional view that atherosclerosis is simply a lipid storage disease has recently been challenged by evidence that inflammation plays a central role in all stages of atherosclerosis. However, molecular mechanisms linking inflammation to atherosclerosis development are not fully understood, and this has severely hampered the advance of diagnostic and therapeutic programs. AtheroRemo aims to identify novel inflammatory mechanisms in vascular remodelling by combining the exploration of human biobanks with animal models and established cellular models. This new knowledge will be used to develop new preventive, diagnostic and therapeutic strategies against atherosclerotic cardiovascular disease. AtheroRemo contains several unique strengths: 1) Outstanding expertise on immunity and inflammation. Our expertise facilitates the breakthroughs in the immuno-inflammatory targeted vascular treatments. 2) Finest European cohorts to search for molecular mechanisms behind atherosclerosis development allowing us to combine underlying genetics with lipidomic profiles in multiple cohorts in order to obtain risk factors and biomarker panel related to inflammatory remodelling. 3) Accelerated target validation with novel liposomal-targeted delivery of nucleic acid-based therapeutics in appropriate animal models. Four SME partners able to exploit the new knowledge support AtheroRemo research. Thus, we expect to translate a number of novel findings into potential clinical applications such as new diagnostic tools (biomarkers) and therapeutics.
Champ scientifique
Mots‑clés
Appel à propositions
FP7-HEALTH-2007-A
Voir d’autres projets de cet appel
Régime de financement
CP-IP - Large-scale integrating projectCoordinateur
33521 Tampere
Finlande
Voir sur la carte
Participants (19)
Participation terminée
02044 VTT ESPOO
Voir sur la carte
17177 Stockholm
Voir sur la carte
SW7 2AZ LONDON
Voir sur la carte
20122 Milano
Voir sur la carte
1211 Geneve
Voir sur la carte
SW17 0RE London
Voir sur la carte
02150 Espoo
Voir sur la carte
89081 Ulm
Voir sur la carte
115 27 Athina
Voir sur la carte
5230 Odense M
Voir sur la carte
5020 Bergen
Voir sur la carte
02150 Espoo
Voir sur la carte
25000 BESANCON
Voir sur la carte
Participation terminée
06120 HALLE
Voir sur la carte
69007 Lyon
Voir sur la carte
3015 GD Rotterdam
Voir sur la carte
85764 Neuherberg
Voir sur la carte
79098 FREIBURG
Voir sur la carte
OX1 2JD Oxford
Voir sur la carte